The day humanity stopped merely reading the genetic code—and attempted to rewrite it.
There was a moment when humanity crossed a line so thin that most people did not realize it had happened.
It was not the birth of a robot.
It was not artificial intelligence becoming conscious.
It was not a laboratory producing a synthetic organism.
It was something much quieter.
A scientist claimed that he had altered the DNA of human embryos—and that those embryos had become children.
In November 2018, Chinese researcher He Jiankui announced that twin girls had been born after their embryos were edited using CRISPR-Cas9. The intended target was CCR5, a gene involved in HIV infection. His stated objective was to make the children less susceptible to HIV.
The announcement detonated across the scientific world.
Because this was no longer simply about treating a patient.
It was about changing a human being before that human being had been born.
And potentially changing the genetic inheritance of future generations.
THE FIRST DISTINCTION WE MUST MAKE
The phrase “engineered human” sounds like science fiction.
It isn’t quite accurate.
We do not currently have the technology to design a human being from scratch—to select a complete personality, intelligence, strength, appearance and lifespan like options on a screen.
That is fiction.
But something much more consequential is real.
Scientists can modify DNA in human cells.
And in some experimental settings, scientists have edited human embryos.
The distinction matters.
There are two fundamentally different worlds.
Somatic editing modifies cells in an existing person. Those changes generally affect only that individual.
Germline or heritable editing modifies reproductive cells, embryos, or cells that contribute to reproduction. Changes could potentially be passed to descendants. The WHO identifies heritable editing as carrying particularly significant safety and ethical concerns.
The first is increasingly becoming medicine.
The second is where the nightmare begins.
CRISPR: THE MOLECULAR EDITOR
CRISPR-Cas9 changed the conversation.
Instead of merely observing DNA, researchers gained a tool capable of making targeted changes to genetic material.
The technology is not magic.
It is not a microscopic computer capable of understanding the entire human body.
It is a biological editing system.
And that distinction is critical.
DNA is extraordinarily complicated.
Changing one genetic sequence can have consequences that researchers may not fully predict.
A gene rarely exists in isolation.
Genes interact with other genes.
Genes interact with cells.
Cells interact with organs.
Organs interact with environments.
And a human being is the result of an extraordinarily complicated biological system.
Changing one instruction does not necessarily produce one predictable result.
That is why the idea of casually creating “designer humans” is scientifically premature.
2017: THE EMBRYO BECOMES THE EXPERIMENT
Before the CRISPR-baby scandal, researchers had already demonstrated that human embryos could be genetically edited in laboratory research.
In 2017, researchers reported using CRISPR-Cas9 to investigate and modify genes in human embryos.
One study examined MYBPC3, a gene associated with hypertrophic cardiomyopathy. Another investigated OCT4, a gene involved in early embryonic development.
These experiments were not equivalent to creating genetically engineered children.
That distinction is crucial.
The embryos were laboratory research material—not a population of engineered humans released into society.
But scientifically, something enormous had changed.
The embryo was no longer an untouchable mystery.
It had become something researchers could experimentally manipulate at the level of DNA.
And the question became unavoidable:
How long before someone decided to implant one?
2018: SOMEONE DID
Then came He Jiankui.
He claimed his team had edited embryos and that the embryos were subsequently implanted, resulting in the birth of twin girls.
The announcement was extraordinary.
But the scientific community immediately questioned the work.
Had the editing been precise?
Were all cells edited in the same way?
Were there unintended genetic changes?
Was the modification actually necessary?
Were the parents adequately informed?
Had the experiment received legitimate ethical approval?
And perhaps the most uncomfortable question:
Who had given the children permission to become the subjects of an irreversible experiment?
Nature reported that He had proceeded despite the international scientific consensus that the technology was not ready or appropriate for clinical germline use.
The controversy became even darker.
Investigations raised serious questions about the ethics approval and consent process. A purported ethics approval document was reportedly found to be fraudulent, while researchers questioned whether participants had been adequately informed about the unknown risks.
This wasn’t merely a scientific mistake.
It became a case study in what happens when technological capability outruns ethical responsibility.
THE CHILDREN WERE NOT “SUPERHUMANS”
This is where sensational stories often go wrong.
The twins were not engineered superhumans.
They were not genetically programmed to be smarter, stronger or immortal.
The editing targeted CCR5 with the goal of reducing susceptibility to HIV.
And even that goal was scientifically complicated.
Disabling CCR5 is not equivalent to creating immunity to every form of HIV.
Furthermore, researchers raised concerns about what unintended consequences might result from altering a gene that performs functions in human biology beyond HIV susceptibility.
One later study reported an association between naturally occurring loss-of-function variants in CCR5 and increased mortality, although that finding does not establish that the particular edits in the twins shortened their lives.
And that distinction illustrates the fundamental problem.
We don’t fully understand the consequences of rewriting biology.
THE MOST TERRIFYING WORD IS “HERITABLE”
Imagine you edit a skin cell.
The change affects that cell lineage.
But imagine editing an embryo.
Now the alteration could potentially become part of the person’s biological inheritance.
That person grows up.
They have children.
Their children may inherit the alteration.
Those children have children.
And suddenly an experimental decision made in one laboratory could become part of a genetic lineage extending far beyond the original experiment.
That is why heritable genome editing is fundamentally different from conventional medicine.
The patient isn’t necessarily the only person affected.
Future generations may become patients who never consented to the experiment.
The WHO explicitly distinguishes heritable genome editing from non-heritable somatic editing and highlights the greater safety and ethical concerns surrounding heritable changes.
BUT HERE IS THE TWIST
While the world was arguing about “designer babies,” another revolution was quietly becoming real.
Scientists were learning how to edit adult human cells for therapeutic purposes.
In December 2023, the U.S. FDA approved Casgevy, making it the first FDA-approved therapy using CRISPR/Cas9. It is used for sickle-cell disease, with a patient’s own blood stem cells edited outside the body and then returned to the patient.
That distinction is enormous.
The objective is not:
“Let’s build a better human.”
It is:
“Let’s repair a biological problem in a person who already exists.”
That is a radically different ethical proposition.
And it demonstrates something important.
Human genome editing is no longer theoretical.
It has entered medicine.
SO WHERE IS THE LINE?
Consider the progression.
Treat a devastating genetic disease.
Prevent an inherited disease.
Modify an embryo to eliminate a serious mutation.
Reduce someone’s susceptibility to infection.
Increase resistance to disease.
Improve physical performance.
Increase muscle mass.
Alter metabolism.
Influence aging.
Modify cognitive traits.
Select combinations of genetic characteristics.
Some of these are scientifically plausible research questions.
Others remain extremely difficult or speculative.
But the technological trajectory forces an uncomfortable question:
Who decides where medicine ends and human enhancement begins?
THE “DESIGNER BABY” PROBLEM
People sometimes imagine the future as a shopping catalogue.
Blue eyes.
Perfect height.
Exceptional intelligence.
Athletic ability.
Long life.
Disease resistance.
But biology doesn’t work like a smartphone configuration screen.
Many human characteristics are polygenic.
Thousands of genetic variants can contribute to complex traits such as height, intelligence and disease susceptibility.
Environment matters.
Nutrition matters.
Education matters.
Chance matters.
Development matters.
And genes interact with each other.
So the idea that scientists can simply locate an “intelligence gene” and turn it up to 100 is profoundly misleading.
The future of genetic engineering may therefore be much stranger than the classic designer-baby fantasy.
It may involve incremental modification of many biological systems, rather than one dramatic genetic switch.
And that makes regulation even harder.
THE REAL FEAR IS NOT SCIENCE
The most frightening possibility isn’t that scientists will suddenly create Superman.
It is that genetic technologies gradually become good enough to make enhancement commercially attractive.
Imagine a future in which some parents can afford advanced genetic interventions and others cannot.
One group receives treatments to prevent certain diseases.
Another begins selecting embryos based on increasingly complex genetic information.
Eventually, enhancement becomes a status symbol.
The wealthy don’t simply buy better education.
They buy biological advantages.
At that point, the issue stops being purely scientific.
It becomes economic.
Political.
Social.
And profoundly human.
What happens when inequality becomes hereditary by design?
THE ETHICAL WALL
In 2020, an international commission convened by the U.S. National Academy of Medicine, National Academy of Sciences and the UK’s Royal Society recommended that no pregnancy involving a genome-edited human embryo should proceed until precise, reliable editing without unwanted changes had been demonstrated.
Their conclusion was blunt:
Those criteria had not yet been met.
The WHO subsequently developed a global governance framework and recommendations covering somatic, germline and heritable genome editing. It emphasized safety, ethics, oversight, international cooperation and mechanisms for dealing with illegal or unsafe research.
And the WHO stated that proceeding with clinical applications of human germline genome editing was irresponsible at that time.
This is important.
Scientists aren’t necessarily saying:
“Never.”
They are saying:
“Not until we understand what we’re doing.”
THE MAN WHO CROSSED THE LINE
He Jiankui’s experiment became a warning to the entire scientific community.
He was sentenced by a Chinese court to three years in prison and fined 3 million yuan for illegal medical practices.
His work became a symbol of scientific ambition without sufficient restraint.
But there is a deeper lesson.
The problem wasn’t that humanity possessed the ability to edit DNA.
The problem was that the ability arrived before humanity had agreed on how that ability should be used.
That is a recurring pattern in history.
We invent.
Then we discover consequences.
We build.
Then we regulate.
We cross boundaries.
Then we ask where the boundaries should have been.
THE NEXT HUMAN MAY NOT LOOK DIFFERENT
This is perhaps the most important point.
The future engineered human might not have glowing eyes.
They might not be 8 feet tall.
They might not possess superhuman strength.
They might look completely ordinary.
The difference could exist inside their cells.
A modified gene.
A corrected mutation.
An altered immune response.
A biological characteristic that future generations inherit.
And nobody looking at that person from across a street would know.
That is what makes genetic engineering fundamentally different from many previous technologies.
The most powerful modification may be invisible.
ARE WE ALREADY ENGINEERING HUMANS?
In one narrow sense:
Yes.
Human cells are being genetically modified.
Human patients have received genome-editing therapies.
Human embryos have been experimentally edited in laboratories.
And at least one researcher crossed the line from embryo editing to attempting to establish pregnancies with edited embryos.
But if by “engineered human” we mean a human being whose entire biological identity was deliberately designed by scientists—
No.
That human does not exist.
Not today.
And anyone claiming otherwise is selling science fiction as fact.
THE QUESTION WE SHOULD REALLY BE ASKING
The first engineered human may not be the most dangerous milestone.
The dangerous milestone may come later.
It could be the moment society stops asking:
“Can we do this?”
and starts asking:
“Why shouldn’t we?”
Because once a technology becomes safe enough, affordable enough and accepted enough, the boundary can move.
Treatment becomes prevention.
Prevention becomes enhancement.
Enhancement becomes optimization.
Optimization becomes expectation.
And eventually, the unmodified human could become the exception.
That future is not inevitable.
It is not scientifically guaranteed.
But the technology has already forced humanity to confront the question.
THE FINAL WARNING
For thousands of years, humans accepted the genetic hand they were dealt.
We could educate ourselves.
We could exercise.
We could build machines.
We could change our environment.
But our underlying biological code remained largely beyond our control.
Now that is changing.
CRISPR and related technologies have demonstrated that DNA is not an untouchable script.
It can be edited.
And that changes something fundamental.
Because the next great revolution may not be about machines replacing humans.
It may be about humans beginning to redesign themselves.
The first attempt has already happened.
The scientific community stopped it from becoming a normal medical procedure.
Regulators responded.
Scientists responded.
The world debated.
But the knowledge cannot be uninvented.
The tools cannot simply be forgotten.
And the question is no longer whether humanity has discovered how to edit human DNA.
We have.
The question is what happens when the technology becomes safer, cheaper, more precise—and someone decides that curing disease isn’t enough.
What happens when parents want more than healthy children?
What happens when governments want stronger citizens?
What happens when corporations sell biological advantages?
What happens when the wealthy can afford enhancements that everyone else cannot?
And what happens when the first generation of deliberately modified humans grows up and asks us why we changed them before they could choose for themselves?
Because perhaps the most frightening thing about the engineered human isn’t the possibility of creating something less human.
Perhaps it is the possibility that we will eventually have to decide what “human” is supposed to mean.
And once we acquire the ability to rewrite the code of life—
who gets to hold the pen?
About the Author
